Recent evidence suggests that the TRAIL pathway can activate the immunological checkpoint protein programmed death-ligand 1 (PD-L1), which has recently been found to play an important role in TRAIL resistance and tumor invasion. This evidence concerns the gene CD274 and neoplasm.